English abstract
Patients with mitral valve disease undergoing cerebrovascular surgery face increased inherent risks
due to their associated cardiac comorbidities. As such, the anaesthetic management of such patients is distinctly
challenging. Simultaneous consideration of both the cerebrovascular and underlying cardiac conditions determines
key anaesthetic issues, as fluids and vasopressors or inotropes need to be titrated according to haemodynamic
variables in order to optimise cerebral blood flow without compromising cardiac function. We report a 45-yearold
female patient with mild mitral stenosis and moderate-to-severe mitral regurgitation who presented to the
Khoula Hospital, Muscat, Oman, in 2016 following a ruptured anterior communicating artery aneurysm requiring
urgent surgical intervention. As highlighted in this case, the VolumeView EV1000™ (Edwards Lifesciences,
Irvine, California, USA) system is a minimially invasive haemodynamic monitor that can help immensely in the
perioperative management of such patients.
